Skip to main content
SpringerLink
Log in

Calcium Antagonists and Calcium Sensitizers

  • Chapter
Calcium: The Molecular Basis of Calcium Action in Biology and Medicine

Abstract

The concept of calcium antagonism was postulated independently and al-most simultaneously by (1969) and (1980). The term calcium antagonists for the drugs which cause vasodilatation by blockade of calcium entry in depolarized arteries was firmly established by Godfraind and Kaba in 1969 and it has been used ever since. The term calcium antagonist has been defined as official nomenclature by the International Union of Pharmacology (IUPHAR). Other terms some-times encountered in the literature are calcium entry blockers, calcium slow channel blockers or calcium blockers. The term calcium antagonists should be adhered to as the official nomenclature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agabiti-Rosei, E., Muiesan, M.L., Rizzoni, D., Zulli, R., Calebich, S., Castellano, M., et al., 1994, Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension, J. Cardiovasc. Pharmacol 24(Suppl. A), S37–S43.

    PubMed  Google Scholar 

  • Alderman, M.H., Cohen, H., Roqune, R. and Medhaven, S., 1997, Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients, Lancet 349, 594–598.

    PubMed  CAS  Google Scholar 

  • Aursnes, I., Litleskare, I., Froyland, H. and Abdelnoor, M., 1995, Association between various drugs used for hypertension and risk of acute myocardial infarction, Blood Press. 4, 157–163.

    PubMed  CAS  Google Scholar 

  • Bernink, P.J.L.M., Prager, G., Schelling, A. and Kobrin, I., 1996, On behalf of the Mibefradil International Study Group. 1996, Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967), Hypertens. 27(Part I), 426–432.

    CAS  Google Scholar 

  • Bond, G., Dal Palu, C., Hansson, L., Magnani, B., Mancia, G., et al., 1993, European Lacidipine Study on Atherosclerosis (ELSA), J. Hypertens. 11(Suppl. 5), S405.

    Google Scholar 

  • Borhani, N.O., Mercuri, M., Borhani, P.A., et al., 1996, Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS), JAMA 276, 785–791.

    PubMed  CAS  Google Scholar 

  • Braun, S., Boyko, V., Behar, S., Reicher-Reiss, H., Shotan, A., et al., 1996, Calcium antagonists and mortality in patients with coronary artery disease: A cohort study of 11,575 patients, J. Am. Coll. Cardiol. 28, 7–11.

    PubMed  CAS  Google Scholar 

  • Brogden, R.N. and McTavish, D., 1995, Nifedipine gastrointestinal therapeutic system (GITS), Drugs 50, 495–512.

    PubMed  CAS  Google Scholar 

  • Bühler, F R., 1995, Antihypertensive care with calcium antagonists, in Hypertension. Pathophysiology, Diagnosis and Management, 2nd edn., J.H. Laragh and B.M. Brenner (eds.), Raven Press, New York, pp. 2801–2814.

    Google Scholar 

  • Byington, R.P., Miller, M.E., Herrington, D., et al., 1997, Rationale, design, and baseline characteristics of the prospective randomized evaluation of the vascular effects of Norvasc Trial (PREVENT), Am. J. Cardiol. 80, 1087–1090.

    PubMed  CAS  Google Scholar 

  • Cafiero, M. and Giasi, M., 1997, Long-term (12-month) treatment with lercanidipine in patients with mild to moderate hypertension, J. Cardiovasc. Pharmacol. 29(Suppl. 2), S45–S49.

    Google Scholar 

  • Catapano, A.L., 1997, Calcium antagonists and atherosclerosis. Experimental evidence, Eur. Heart J. 18(Suppl. A), A80–A86.

    PubMed  CAS  Google Scholar 

  • Catterall, W.A., 1993, Structure and function of voltage-gated ion channels, Trends Neurosci. 16, 500–506.

    PubMed  CAS  Google Scholar 

  • Dahlöf, B., Hansson, L., Lindholm, L.H., Schersten, B., Wester, P.O., Ekbom, Y, et al., 1993, STOP-Hypertension-2: A prospective intervention trial of’ newer’ versus’ older’ treatment alternatives in old patients with hypertension, Blood Press. 2, 136–141.

    PubMed  Google Scholar 

  • The Danish Study Group on Verapamil in Myocardial Infarction, 1990, Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II), Am. J. Cardiol. 66, 779–785.

    Google Scholar 

  • Dargie, H.J., Ford, I., Fox, K.M., on behalf of the TIBET (Total Ischaemic Burden European Trial) study group, 1996, Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina, Eur. Heart J. 17, 104–112.

    PubMed  CAS  Google Scholar 

  • Davies, R.F., Hbibi, H., Davies, R., et al., 1995, Effects of amlodipine, atenolol and their combination on myocardial ischaemia during treadmill exercise and ambulatory monitoring, J. Am. Coll. Card. 25, 619–625.

    CAS  Google Scholar 

  • Davis, B.R., Cutler, J.A., Gordon, D.J., et al., for the ALLHAT-Research Group, 1996, Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack (ALLHAT), Am. J. Hypertens. 9, 342–360.

    PubMed  CAS  Google Scholar 

  • Devereux, R.B., 1997, Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy?, Circulation 95, 1983–1985.

    PubMed  CAS  Google Scholar 

  • Dustan, H.R, 1987, Nitrendipine in black US patients, J. Cardiovasc. Pharmacol. 9(Suppl. 4), 267–271.

    Google Scholar 

  • Fischer Hansen, J., 1992, Secondary prevention with calcium antagonists after acute myocardial infarction, Drugs 44, 33–43.

    Google Scholar 

  • Fleckenstein, A. and Fleckenstein-Grün, G., 1980, Cardiovascular protection by CA-antagonists, Eur. Heart J. 1, 15–21.

    PubMed  CAS  Google Scholar 

  • Fodor, J.G., 1997, Nisoldipine CC: Efficacy and tolerability in hypertension and ischemic heart disease, Cardiovasc. Drugs Ther. 10, 873–879.

    PubMed  Google Scholar 

  • Fujii, S., Kameyama, K., Hosono, M., Hayashi, Y. and Kitamura, K., 1997, Effect of cilnidipine, a novel dihydropyridine Ca2+-channel antagonist, on N-type Ca2+-channel in rat dorsal root ganglion neurons, J. Pharmacol. Exp. Ther. 280, 1184–1191.

    PubMed  CAS  Google Scholar 

  • Furberg, C.D., Psaty, B.M. and Meyer, J.V., 1995, Nifedipine. Dose-related increase in mortality in patients with coronary heart disease, Circulation 92, 1326–1330.

    PubMed  CAS  Google Scholar 

  • Godfraind, T. 1997, Vasodilators and calcium antagonists, in Antihypertensive Drugs, P.A. van Zwieten and W.J. Greenlee (eds.), Harwood Academic Publishers, Amsterdam, pp. 313–375.

    Google Scholar 

  • Godfraind, T. and Kaba, A., 1969, Blockade or reversal of contraction induced by calcium and adrenaline in depolarized arterial smooth muscle, Br. J. Pharmacol. 36, 549–560.

    PubMed  CAS  Google Scholar 

  • Godfraind, T., Miller, R.C. and Wibo, M., 1986, Calcium antagonism and calcium entry blockade, Pharmac. Rev. 38, 321–416.

    CAS  Google Scholar 

  • Gong, L., Zhang, W., Zhy, Y and Zhu, J., 1996, Shanghai Trial of Nifedipine in the Elderly (STONE), J. Hypertens. 14, 1237–1245.

    PubMed  CAS  Google Scholar 

  • Göthert, M. and Molderings, G.J., 1997, Mibefradil and ω-conotoxin GVIA-induced inhibition of noradrenaline release from the sympathetic nerves of the human heart, Naunyn-Schmiedeb. Arch. Pharmacol. 356, 860–863.

    Google Scholar 

  • Gray Ellrodt, A. and Singh, B.N., 1983, Clinical applications of slow channel blocking compounds, Clin. Pharmacol. Ther. 23, 1–43.

    Google Scholar 

  • Guarneri, L., Sironi, G., Angelico, P., Ibba, M., Greto, L., et al., 1997, In vitro and in vivo vascular selectivity of lercanidipine and its enantiomers, J. Cardiovasc. Pharmacol. 29(Suppl. 1), S25–S32.

    Google Scholar 

  • Hansson, L., Zanchetti, A. and Carruthers, S.G., 1998, Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial, Lancet 351, 1755–1762.

    PubMed  CAS  Google Scholar 

  • Hansten, Ph.D., 1992, Important drug interactions, in Basic and Clinical Pharmacology, 5th edn., B.G. Katzung (ed.), Prentice-Hall, Englewoods Cliffs, NJ, pp. 931–942.

    Google Scholar 

  • Henry, P.D., 1990, Calcium antagonists as anti-atherosclerotic agents, Arteriosclerosis 10, 963–965.

    PubMed  CAS  Google Scholar 

  • Hess, P., Lansman, J.B. and Tsien, R.W., 1984, Different modes of Ca-channel gating behaviour favoured by dihydropyridine Ca-agonists and-antagonists, Nature 311, 538–544.

    PubMed  CAS  Google Scholar 

  • Hess, P., Lansman, J.B. and Tsien, R.W., 1986, Calcium channel selectivity for divalent and monovalent cations, J. Gen. Physiol. 88, 293–319.

    PubMed  CAS  Google Scholar 

  • Holland Interuniversity Nifedipine-metoprolol Trial (HINT) Research Group, 1986, Early treatment of unstable angina in the coronary care unit: A randomised, double blind, placebo-controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both, Br. Heart J. 56, 400–413.

    Google Scholar 

  • Kaplan, J.A., 1989, The role of nicardipine during anesthesia and surgery, Clin. Ther. 11, 84–93.

    PubMed  CAS  Google Scholar 

  • Kiowski, W., Linder, L. and Bühler, F.R., 1990, Arterial vasodilator and antihypertensive effects of diltiazem, J. Cardiovasc. Pharmacol 16(Suppl. 6), S7–S10.

    PubMed  Google Scholar 

  • Leonetti, G., 1991, Clinical position of lacidipine, a new dihydro-pyridine calcium antagonist, in the treatment of hypertension, J. Cardiovasc. Pharmacol. 18(Suppl. 11), S18–S21.

    PubMed  Google Scholar 

  • Lever, A.F., 1997, Calcium antagonists and cancer, 8th European Meeting on Hypertension, Milan, June 1997.

    Google Scholar 

  • Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B. and Castelli, W.P., 1989, Left ventricular mass and incidence of coronary heart disease in an elderly cohort: The Framingham Heart Study, Ann. Intern. Med. 110, 101–107.

    PubMed  CAS  Google Scholar 

  • Lichtlen, P.R., Hugenholtz, P.G., Rafflenbeul, W., Hecker, H., Jost, S. and Deckers, J.W., 1990, Retardation of angiographic progression of coronary artery disease by nifedipine. Results of an international nifedipine trial on anti-atherosclerotic therapy (INTACT), Lancet 335, 1109–1113.

    PubMed  CAS  Google Scholar 

  • Liebson, RR., Grandits, G.A., Dianzumba, S., Prineas, R.J., Grimm, R.H., et al., 1995, for the Treatment of Hypertension Study Research Group. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOHMS), Circulation 91, 698–706.

    PubMed  CAS  Google Scholar 

  • Lüscher, T.F., Clozel, J.P. and Noll, G., 1997, Pharmacology of the calcium antagonist mibefradil, J. Hypertens. 15(Suppl. 3), S11–S18.

    Google Scholar 

  • Malbantgil, I., Önder, R., Killiçcioglu, B., Boydak, B., Terzioglu, U. and Yilmaz, H., 1996, The efficacy of felodipine ER on regression of left ventricular hypertrophy in patients with primary hypertension, Blood Press. 5, 285–291.

    Google Scholar 

  • Mancia, G. and van Zwieten, P.A., 1996, How safe are calcium antagonists in hypertension and coronary heart disease?, J. Hypertens. 14, 13–17.

    PubMed  CAS  Google Scholar 

  • Matsuzaki, K., Mukai, M., Sumimoto, T. and Murakami, E., 1997, Effects of ACE-inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension, Hypertens. Res. 20, 7–10.

    PubMed  CAS  Google Scholar 

  • Mehrke, G., Zong, X.G., Flockerzi, V. and Hofmann, F., 1994, The Ca++ channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels, J. Pharmacol. Exp. Then 271, 1483–1488.

    CAS  Google Scholar 

  • Minami, J., Ishimitsu, T., Kawano, Y., Numabe, A. and Matsuoka, H., 1998, Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard, J. Cardiovasc. Pharmacol 32, 331–336.

    PubMed  CAS  Google Scholar 

  • Mishra, S.K. and Hermsmeyer, K., 1994, Selective inhibition of T-type Ca2+-channels by Ro 40-5967, Circ. Res. 75, 144–148.

    PubMed  CAS  Google Scholar 

  • Muiesan, G., Agabiti-Rosei, E., Castellano, M., Alicandri, C.L., Corea, L., Fariello, R., et al., 1982, Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension, J. Cardiovasc. Pharmacol 4(Suppl. 3), S325–S329.

    PubMed  Google Scholar 

  • Müller, F.B., Ha, H.R., Hotz, M., Schmidlin, O., Follath, F. and Bühler, F., 1985, Once a day verapamil in essential hypertension, Br. J. Clin. Pharmacol. 21(Suppl. 2), 143S–147S.

    Google Scholar 

  • The Multicenter Diltiazem Postinfarction Trial Research Group, 1988, The effect of diltiazem on mortality and reinfarction after myocardial infarction, New Engl. J. Med. 319, 385–392.

    Google Scholar 

  • Murdoch, D. and Heel, R.C., 1991, Amlodipine, Drugs 41, 478–505.

    PubMed  CAS  Google Scholar 

  • Nayler, W.G., 1988a, Calcium Antagonists Academic Press, Harcourt Brace Jovanovich Publishers, London, pp. 1–347.

    Google Scholar 

  • Nayler, W.G., 1988b, Calcium antagonists and myocardial ischaemia, in Calcium Antagonists, W.G. Nayler (ed.), Academic Press, New York, pp. 157–176.

    Google Scholar 

  • Nielsen Kudsk, J.E. and Addershvile, J., 1995, Will calcium sensitizers play a role in the treatment of heart failure?, J. Cardiovasc. Pharmacol. 26(Suppl. 1), S77–S84.

    PubMed  CAS  Google Scholar 

  • Nijhawan, N., Nicolosi, A.C., Montgomery, M.N., Aggarwal, A., Pagel, P.S. and Warltier, D.C., 1999, Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized, placebo-controlled trial, J. Cardiovasc. Pharmacol. 34, 219–228.

    PubMed  CAS  Google Scholar 

  • NORDIL Study Group, 1993, The NORDIC Diltiazem Study: An intervention study in hyper-tension comparing calcium antagonist based treatment with conventional therapy, Blood Press. 2, 312–321.

    Google Scholar 

  • Opie, L.H., 1990, Clinical Use of Calcium Channel Antagonistic Drugs, 2nd edn., Kluwer Academic Publishers, Boston, pp. 70–130.

    Google Scholar 

  • Packer, M., O’Connor, CM., Ghali, J.K., et al., 1996, Effects of amlodipine on morbidity and mortality in severe chronic heart failure, New Engl. J. Med. 335, 1107–1114.

    PubMed  CAS  Google Scholar 

  • Pahor, M., Guralnik, J.M., Corti, M., Foley, DJ., Carbonin, P. and Havlik, J.R., 1995, Long-term survival and use of antihypertensive medications in older persons, J. Am. Ger. Soc. 43, 1–7.

    Google Scholar 

  • Pahor, M., Guralnik, J., Salive, M., Corti, M., Carbonin, P. and Havlik, R., 1996a, Do calcium channel blockers increase the risk of cancer?, J. Hypertens. 9, 695–699.

    CAS  Google Scholar 

  • Pahor, M., Guralnik, J., Furberg, C., Carbonin, P. and Havlik, R., 1996b, Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old, Lancet 347, 1061–1065.

    PubMed  CAS  Google Scholar 

  • Pedrinelli, R., Fouad, F.M., Tarazi, R.C., Bravo, E.L. and Textor, S.C., 1986, Nitrendipine, a calcium entry blocker. Renal and humoral effects in human arterial hypertension, Arch. Intern. Med. 146, 62–65.

    PubMed  CAS  Google Scholar 

  • Pfaffendorf, M., Mathy, M.J. and van Zwieten, P.A., 1993, In vitro effects of nifedipine, nisoldipine, and lacidipine on rat isolated coronary small arteries, J. Cardiovasc. Pharmacol. 21,496–502.

    PubMed  CAS  Google Scholar 

  • Plosker, G.L. and Faulds, D., 1996, Nisoldipine Coat-Core. A review of its pharmacology and therapeutic efficacy in hypertension, Drugs 52, 232–253.

    PubMed  CAS  Google Scholar 

  • Portegies, M.C.M., Schmitt, R., Kraaij, C.J., et al., 1991, Lack of negative inotropic effect of a new calcium antagonist Ro 40-5967 in patients with stable angina pectoris, J. Cardiovasc. Pharmacol. 18, 746–751.

    PubMed  CAS  Google Scholar 

  • PREVENT Trial, 1998, Communication at the 71st Scientific Sessions of the American Heart Association, Dallas USA, November 1998.

    Google Scholar 

  • Psaty, B.M., Heckbert, S.R., Koepsell, T.D., Sisovick, D.S., Raghunathan, T.E., Weiss, N.S., et al., 1995, The risk of myocardial infarction associated with antihypertensive drug therapies, JAMA 274, 620–625.

    PubMed  CAS  Google Scholar 

  • Rehnqvist, N., Hjemdahl, P., Billing, E., et al., 1996, Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS), Eur. Heart. J. 17,76–81.

    PubMed  CAS  Google Scholar 

  • Ribstein, J., de Treglode, D., Mimran, A., 1985, Acute effects of nifedipine on arterial pressure in healthy subjects and hypertensives, Arch. Mal. Coeur 78, 29–32.

    PubMed  Google Scholar 

  • Rodicio, J.L., 1996, Renal effects of calcium antagonists with special reference to manidipine hydrochloride, Blood Press. 5(Suppl. 5), 10–15.

    CAS  Google Scholar 

  • Rodicio, J.L., Morales, J.M., Alcazar, M. and Ruilope, L.M., 1993, Calcium antagonists and renal protection, J. Hypertens. 11, S49–S53.

    CAS  Google Scholar 

  • Rubin, P., 1995, Prescribing in Pregnancy, 2nd edn., BMJ Publishing Group, London, pp. 99–102.

    Google Scholar 

  • Ruegg, J.C. and Morano, I., 1989, Calcium sensitivity modulation of cardiac myofibrillar proteins, J. Cardiovasc. Pharmacol 14(Suppl. 3), S20–S23.

    PubMed  CAS  Google Scholar 

  • Schmieder, R.E., Messuli, F.H., Garavglio, G.E. and Nunes, B.D., 1987, Cardiovascular effects of verapamil in essential hypertension, Circulation 76, 1143–1155.

    Google Scholar 

  • Sever, P., 1986, 1985, The year of the hypertension trials, Trends Pharmacol Sci. 6, 134–139.

    Google Scholar 

  • Sheperd, J., et al., 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia, New Engl. J. Med. 333, 1301–1307.

    Google Scholar 

  • Sher, E., Biancardi, E., Passafaro, M. and Clementi, F., 1991, Physiopathology of neuronal voltage-operated calcium channels, FASEB J. 5, 2677–2683.

    PubMed  CAS  Google Scholar 

  • Staessen, J.A., et al., for the Systolic Hypertension in Europe Trial (SYST-EUR), 1997, Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension, Lancet 350, 757–764.

    PubMed  CAS  Google Scholar 

  • Stockley, I.H., 1994, Drug Interactions, 3rd edn., Blackwell, Oxford.

    Google Scholar 

  • Struyker Boudier, H.A.J., de Mey, J.G., Smits, J.F.M. and Nievelstein, H.M.N.W., 1989, Hemodynamic actions of calcium entry blockers, in Clinical Aspects of Calcium EntryvBlockers, P.A. van Zwieten (ed.), Karger Verlag, Basel, pp. 21–66.

    Google Scholar 

  • Thürmann, P.A., Stephens, N., Heagerty, A.M., Kenedi, P., Weidinger, G. and Rietbrock, N., 1996, Influence of isradipine and Spirapril on left ventricular hypertrophy and resistance arteries, Hypertension 28, 450–456.

    PubMed  Google Scholar 

  • Tijssen, J.G.P. and Hugenholtz, P.G., 1996, Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary heart disease and hypertension, Eur. Heart J. 17, 1152–1157.

    PubMed  CAS  Google Scholar 

  • Timmermans, P.B.M.W.M. and van Zwieten, P.A., 1982, α 2-Adrenoceptors. Classification, localisation, mechanisms and targets for drugs, J. Med. Chem. 25, 1389–1401.

    PubMed  CAS  Google Scholar 

  • Tsien, R.W. and Tsien, R.Y., 1990, Calcium channels, stores and oscillations, Ann. Rev. Cell. Biol 6, 715–760.

    PubMed  CAS  Google Scholar 

  • Underwood, S.M., Davies, S.W., Feneck, R.O., Lunnon, M.W. and Walesby, R.K., 1991, Comparison of isradipine with nitroprusside for control of blood pressure following myocardial revascularization: Effects on hemodynamics, cardiac metabolism and coronary blood flow, J. Cardiothorac. Vasc. Anesth. 5, 348–356.

    PubMed  CAS  Google Scholar 

  • Van Heiningen, P.N.M. and van Zwieten, P.A., 1988, Differential sensitivity to calcium entry blockade of angiotensin II-induced contractions of rat and guinea-pig aorta, Arch. Int. Pharmacodyn. 296, 118–130.

    PubMed  Google Scholar 

  • Van der Lee, R., Pfaffendorf, M. and van Zwieten, P.A., 1997, Effects of mibefradil and other calcium antagonists on microvessels of different end organs, 8th European Meeting on Hypertension, Milan, June 1997.

    Google Scholar 

  • Van der Lee, R., Pfaffendorf, M., De Mey, J.G.R. and van Zwieten, P.A., 2000, Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in rat tail artery, Naunyn-Schmiedeb. Arch. Pharmacol. 361, 74–79.

    Google Scholar 

  • Van Meel, J.C.A., de Jonge, A.J., Kalkman, H.O., Wilffert, B., Timmermans, P.B.M.W.M. and van Zwieten, P.A., 1981, Vascular smooth muscle contraction initiated by postsynaptic α 2-adrenoceptor activation is induced by an influx of extracellular calcium, Eur. J. Pharmacol 69, 205–208.

    PubMed  Google Scholar 

  • Van Zwieten, P.A., 1985, Drug targets in unstable angina, in Unstable Angina, Current Concepts and Management, P.G. Hugenholtz (ed.), Schattauer Verlag, Stuttgart, pp. 151–157.

    Google Scholar 

  • Van Zwieten, P.A., 1989, Clinical aspects of calcium entry blockers, Progr. Basic Clin. Pharmacol. 2, 1–20.

    Google Scholar 

  • Van Zwieten, P.A., 1992, Therapy update — What is new? Calcium antagonists, Neth. J. Cardiol. 5, 17–22.

    Google Scholar 

  • Van Zwieten, P.A., 1998, The newer calcium antagonists, Cardiologie 5, 4–13.

    Google Scholar 

  • Van Zwieten, P.A. and Lie, K.I., 1995, Long term efficacy and safety of calcium antagonists, Cardiologie 2, 457–460.

    Google Scholar 

  • Van Zwieten, P.A. and Pfaffendorf, M., 1994, New aspects of the pharmacology of dihydropyridine calcium antagonists, JAMA SE Asia 15(Suppl.), 9–19.

    Google Scholar 

  • Van Zwieten, P.A. and van Wezel, H.B., 1993, Antihypertensive drug treatment in the perioperative period, J. Cardiothorac. Vasc. Anesth. 7, 213–226.

    PubMed  Google Scholar 

  • Van Zwieten, P.A., Timmermans, P.B.M.W.M. and van Heiningen, P.N.M., 1987, Receptor subtypes involved in the action of calcium antagonists, J. Hypertens. 5(Suppl. 4), S21–S28.

    Google Scholar 

  • Visser, CA., Koolen, J.J., van Wezel, H.B., Jonges, R., Hoedemaker, G. and Dunning, A.J., 1986, Effects of intracoronary nicardipine and nifedipine on left ventricular function and coronary sinus blood flow, Br. J. Clin. Pharmacol. 22(Suppl. 2), 313S–318S.

    Google Scholar 

  • Wagenknecht, L., Furberg, C., Hammon, J., Legault, C. and Troost, B., 1995, Surgical bleeding: Unexpected effect of a calcium antagonist, Br. Med. J. 310, 776–777.

    CAS  Google Scholar 

  • Waters, D., 1991, Proischemic complications of dihydropyridine calcium channel blockers, Circulation 84, 2598–2600.

    PubMed  CAS  Google Scholar 

  • Waters, D., Lespérence, J., Francetich, M., et al., 1990, A controlled clinical trial to assess the effects of a calcium channel blocker on the progression of coronary atherosclerosis, Circulation 82, 1940–1953.

    PubMed  CAS  Google Scholar 

  • WHO-ISH Study, Ad hoc subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension, 1997, Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding, J. Hypertens. 15, 105–115.

    Google Scholar 

  • Zanchetti, A., on behalf of the Italian nifedipine-GITS study group, 1994, The 24-hour efficacy of a new once-daily formulation of nifedipine, Drugs 49(Suppl. 1), 23–31.

    Google Scholar 

  • Zanchetti, A., 1996, Antiatherosclerotic effects of antihypertensive drugs: Recent evidence and ongoing trial, Clin. Exp. Hypertens. 18, 489–499.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pharmacotherapy, Cardiology, and Cardiopulmonary Surgery, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands

    P. A. van Zwieten

Authors
  1. P. A. van Zwieten
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Université Libre de Bruxelles, Belgium

    Roland Pochet

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

van Zwieten, P.A. (2000). Calcium Antagonists and Calcium Sensitizers. In: Pochet, R., Donato, R., Haiech, J., Heizmann, C., Gerke, V. (eds) Calcium: The Molecular Basis of Calcium Action in Biology and Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0688-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0688-0_21

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-6422-1

  • Online ISBN: 978-94-010-0688-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation